← FDA DRUG APPROVALS

FDA ANDA · ANDA080820

LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE

Sponsor: BEL MAR

APPLICATION
ANDA080820
TYPE
ANDA
ORIGINAL APPROVAL
1973-12-03
LATEST ACTION
1973-12-03
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINEDiscontinued
EPINEPHRINE 0.01MG/ML, LIDOCAINE HYDROCHLORIDE 1% · INJECTABLE · INJECTION

Approval history

1973-12-03OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →